117 related articles for article (PubMed ID: 1686059)
21. Displacement by alpha-adrenergic agonists and antagonists of 3H-prazosin bound to the alpha-adrenoceptors of the dog aorta and the rat brain.
Nagatoma T; Tsuchihashi H; Sasaki S; Nakagawa Y; Nakahara H; Imai S
Jpn J Pharmacol; 1985 Feb; 37(2):181-7. PubMed ID: 2860265
[TBL] [Abstract][Full Text] [Related]
22. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.
Greengrass P; Bremner R
Eur J Pharmacol; 1979 May; 55(3):323-6. PubMed ID: 37098
[TBL] [Abstract][Full Text] [Related]
23. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
24. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
Howe JR; Yaksh TL
Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820
[TBL] [Abstract][Full Text] [Related]
25. Characterization of bunazosin-sensitive alpha1-adrenoceptors in human renal medulla.
Yasuda G; Umemura S; Ishii M
J Cardiovasc Pharmacol; 1997 Aug; 30(2):163-8. PubMed ID: 9269942
[TBL] [Abstract][Full Text] [Related]
26. Selective blockade of alpha 1-adrenoceptors of porcine vascular smooth muscle cells by bunazosin.
Nishimura J; Kanaide H; Miwa-Nishimura N; Nakamura M
Arzneimittelforschung; 1989 Jun; 39(6):668-9. PubMed ID: 2570581
[TBL] [Abstract][Full Text] [Related]
27. Binding of [3H]prazosin and [3H]p-aminoclonidine to alpha-adrenoceptors in rat spinal cord.
Simmons RM; Jones DJ
Brain Res; 1988 Apr; 445(2):338-49. PubMed ID: 2836025
[TBL] [Abstract][Full Text] [Related]
28. Influence of steroid hormone treatments or pregnancy on [3H]prazosin and [3H]rauwolscine binding to myometrial alpha-adrenoceptors in the ewe.
Vass-Lopez A; Garcia-Villar R; Lafontan M; Toutain PL
J Endocrinol; 1990 Dec; 127(3):471-9. PubMed ID: 1704044
[TBL] [Abstract][Full Text] [Related]
29. High-affinity specific [3H]tamsulosin binding to alpha 1-adrenoceptors in human prostates with benign prostatic hypertrophy.
Yamada S; Tanaka C; Ohkura T; Mori R; Kimura R; Inagaki O; Honda K; Kawabe K
Urol Res; 1994; 22(5):273-8. PubMed ID: 7533443
[TBL] [Abstract][Full Text] [Related]
30. Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.
Büscher R; Heeks C; Taguchi K; Michel MC
Br J Pharmacol; 1996 Feb; 117(4):703-11. PubMed ID: 8646417
[TBL] [Abstract][Full Text] [Related]
31. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia.
Lepor H; Gup DI; Baumann M; Shapiro E
Urology; 1988 Dec; 32(6 Suppl):21-6. PubMed ID: 2462301
[TBL] [Abstract][Full Text] [Related]
32. [Quantitative analyses of human prostatic alpha-adrenoceptors and effects of terazosin on the alpha-adrenoceptor activity].
Morita T
J Smooth Muscle Res; 1991 Jun; 27(3):149-54. PubMed ID: 1726720
[TBL] [Abstract][Full Text] [Related]
33. Alpha 1 adrenoceptor subtype mediates noradrenaline induced contraction of the human internal mammary artery: radioligand and functional studies.
Bevilacqua M; Vago T; Monopoli A; Baldi G; Forlani A; Antona C; Biglioli P; Scrofani R; Norbiato G
Cardiovasc Res; 1991 Apr; 25(4):290-4. PubMed ID: 1653111
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
35. Alterations of binding characteristics of alpha 1-,beta 1-adrenoceptors and Ca2+ binding sites in the myocardium of spontaneously hypertensive rats (SHR) by chronically administered bunazosin, atenolol, ketanserin and verapamil.
Watanabe K; Shibata A; Wakabayashi H; Shimada K; Tsuchihashi H; Nagatomo T
Biol Pharm Bull; 1993 May; 16(5):480-2. PubMed ID: 8103393
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of alpha 1 adrenergic receptors in the canine prostate using [125I]-Heat.
Lepor H; Baumann M; Shapiro E
J Urol; 1987 Nov; 138(5):1336-9. PubMed ID: 2822972
[TBL] [Abstract][Full Text] [Related]
37. Binding and functional properties of doxazosin in the human prostate adenoma and canine brain.
Lepor H; Baumann M; Shapiro E
Prostate; 1990; 16(1):29-38. PubMed ID: 1968249
[TBL] [Abstract][Full Text] [Related]
38. Selective enrichment with alpha 1A- and alpha 1B-adrenoceptor subtypes in rat brain cortical membranes.
Sallés J; Badia A
Eur J Pharmacol; 1994 Feb; 266(3):301-8. PubMed ID: 7909753
[TBL] [Abstract][Full Text] [Related]
39. Characterization of [3H]atipamezole as a radioligand for alpha 2-adrenoceptors.
Sjöholm B; Voutilainen R; Luomala K; Savola JM; Scheinin M
Eur J Pharmacol; 1992 Apr; 215(1):109-17. PubMed ID: 1355439
[TBL] [Abstract][Full Text] [Related]
40. Alterations in alpha adrenergic receptors in human cerebral arteries after subarachnoid hemorrhage.
Tsukahara T; Taniguchi T; Fujiwara M; Handa H; Nishikawa M
Stroke; 1985; 16(1):53-8. PubMed ID: 2981441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
